lung cancer – Medxy AI

Exercise Reverses Obesity-Driven Immune Dysfunction in Lung Cancer: New Insights for Therapy and Prevention

By MedXY 08/25/2026

Physical activity counteracts adiposity-induced immune suppression in lung cancer and non-tumor lungs, restoring antitumor immunity and slowing tumor progression, with implications for lung cancer interception.

Clinical Updates General Surgery news Oncology

Single-Encounter Augmented Reality-Guided Localization Enhances Early-Stage Lung Cancer Resection: Review of a Pivotal Randomized Clinical Trial

By MedXY 07/11/2026

This review synthesizes evidence on AR-guided single-encounter localization for early-stage lung cancer, highlighting its noninferiority to CT-guided methods with benefits in patient comfort, radiation reduction, and procedural efficiency.

news Oncology Respiratory

Symptom Prevalence in Lung Cancer Screening: Insights from the SUMMIT Study

By MedXY 07/02/2026

The SUMMIT study reveals that respiratory symptoms are common among lung cancer screening participants and associated with increased lung cancer diagnosis risk within one year, challenging conventional asymptomatic screening definitions.

Clinical Updates General Surgery news Oncology

Enhancing Lung Cancer Surgical Quality: Insights from the American College of Surgeons’ National Quality Improvement Collaborative

By MedXY 06/25/2026

This review synthesizes current evidence on lung cancer surgical quality improvement, highlighting the impactful American College of Surgeons Lung NODES Collaborative's success in improving lymph node sampling compliance and broader advances in perioperative care, radiation therapy, and risk stratification.

news Oncology Psychiatry

When Severe Mental Illness Meets Lung Cancer: Why Equal Treatment Still Isn’t Guaranteed

By MedXY 05/29/2026

A large Japanese study found that people with schizophrenia spectrum disorders were less likely to receive several standard treatments for non-small cell lung cancer, underscoring a persistent and preventable gap in cancer care.

news Oncology Respiratory

Histologic Subtype Dictates the Survival Benefit of Guideline-Adherent Lymph Node Dissection in T1N0M0 Lung Adenocarcinoma

By MedXY 01/27/2026

A large-scale multicenter study reveals that adherence to lymph node dissection guidelines significantly improves survival in early-stage lung adenocarcinoma patients with high-grade histologic patterns, while offering no significant benefit for those with low-risk lepidic-predominant tumors.

news Oncology Respiratory

Precision Management of KRAS G12V-Mutated NSCLC: Molecular Insights and Therapeutic Strategies

By MedXY 01/11/2026

This article synthesizes recent findings on the KRAS G12V mutation in non-small cell lung cancer, highlighting its unique molecular profile, strong association with smoking, and superior response to immunotherapy compared to traditional chemotherapy.

news Oncology Radiology

PET/CT-Guided Discontinuation of Immunotherapy in Metastatic Lung Cancer: A Paradigm Shift Toward Precision De-escalation

By MedXY 01/10/2026

A landmark study from the nNGM reveals that PET/CT-guided discontinuation of immunotherapy in long-term lung cancer responders significantly improves survival and identifies second primary cancers, challenging the current practice of indefinite treatment.

Clinical Updates news Oncology

Risk and Outcomes of Secondary Cancer Among Lung Cancer Survivors After Definitive Treatment: A Comprehensive Review

By MedXY 12/13/2025

This review synthesizes evidence on the incidence, risk factors, and outcomes of secondary cancers in non-small cell lung cancer survivors post-definitive therapy, highlighting genetic predisposition as a key determinant distinct from recurrence patterns.

Oncology Psychiatry Specialties

Esketamine in Lung Cancer Patients with Major Depression: Efficacy for Smoking Cessation and Treatment-Resistant Depression

By MedXY 08/25/2025

This review synthesizes evidence from a randomized trial and real-world studies showing esketamine's efficacy and safety in smoking cessation among lung cancer patients with MDD, as well as in treatment-resistant depression, highlighting cognitive benefits and long-term safety.

Clinical Updates news Oncology Specialties

A Century of Change: How Human Innovation Transformed Lung Cancer Treatment

By MedXY 08/03/2025

Lung cancer therapy has evolved from rudimentary surgery and misdiagnosis to a precision medicine era, markedly improving outcomes through targeted therapies and immunotherapy.